Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CANCER,NOS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00250068
What this trial is testing

Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)

Who this might be right for
Lung DiseasesCancer
University of New Mexico 8
Not applicableUnknownNCT04837950
What this trial is testing

Changes in Pleural Cavity Volume and Surgical Exposure

Who this might be right for
Thoracic Cancer
Odense University Hospital 40
Not applicableWithdrawnNCT01434550
What this trial is testing

Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Tumor
H. Lee Moffitt Cancer Center and Research Institute
Not applicableStudy completedNCT01631318
What this trial is testing

Pilot 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Liver Metastases

Who this might be right for
Liver MetastasesColon Cancer
Stanford University 34
Testing effectiveness (Phase 2)Looking for participantsNCT06161818
What this trial is testing

Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction

Who this might be right for
Esophageal CancerAdenocarcinoma of the Esophagus
Erasmus Medical Center 216
Testing effectiveness (Phase 2)Study completedNCT00206518
What this trial is testing

Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients

Who this might be right for
Breast Cancer
Mothaffar Rimawi 167
Testing effectiveness (Phase 2)Study completedNCT00014690
What this trial is testing

ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
AstraZeneca
Testing effectiveness (Phase 2)Looking for participantsNCT04724018
What this trial is testing

Sacituzumab Govitecan Plus EV in Metastatic UC

Who this might be right for
Urothelial CancerMetastatic Urothelial CarcinomaMetastatic Urothelial Carcinoma of the Renal Pelvis and Ureter+1 more
Dana-Farber Cancer Institute 106
Early research (Phase 1)Study completedNCT00003890
What this trial is testing

MG98 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 19
Not applicableLooking for participantsNCT05831397
What this trial is testing

Extracellular Vesicles in Breast Cancer Patientsin Undergone Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Istituti Clinici Scientifici Maugeri SpA 35
Not applicableLooking for participantsNCT01247597
What this trial is testing

DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study

Who this might be right for
Pleuropulmonary BlastomaCystic NephromaOvarian Sertoli-Leydig Cell Tumors+2 more
National Cancer Institute (NCI) 1,500
Testing effectiveness (Phase 2)Active Not RecruitingNCT04127110
What this trial is testing

Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 68
Testing effectiveness (Phase 2)Ended earlyNCT00845910
What this trial is testing

Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 22
Not applicableStudy completedNCT05932810
What this trial is testing

Evaluation of a Proactive Identification and Digital Mental Health Intervention Approach to Address Unmet Psychosocial Needs of Individuals Living With Cancer

Who this might be right for
DepressionDepressive SymptomsCancer
Medical University of South Carolina 30
Not applicableStudy completedNCT00754910
What this trial is testing

Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Non-Small Cell Lung Cancer And Bronchial Disease

Who this might be right for
Lung Cancer
Ohio State University Comprehensive Cancer Center 35
Not applicableLooking for participantsNCT06359210
What this trial is testing

Sustaining Physical Activity After Cancer Exercise Sessions

Who this might be right for
Exercise OncologyPhysical Activity BehaviorBehavior Change Interventions
Colorado State University 105
Large-scale testing (Phase 3)Study completedNCT00652938
What this trial is testing

Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 744
Testing effectiveness (Phase 2)Looking for participantsNCT06903858
What this trial is testing

Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer

Who this might be right for
Colorectal CancerMicrosatellite Instability HighMismatch Repair Deficiency
Sun Yat-sen University 105
Testing effectiveness (Phase 2)Study completedNCT00003158
What this trial is testing

S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 96
Not applicableUnknownNCT03523078
What this trial is testing

Cosmetic Outcome, Patient-reported Outcomes, and Reconstruction-related Complications in Breast Cancer Women Treated With or Without Post-mastectomy Radiation Therapy

Who this might be right for
Breast Cancer Female
Yonsei University 500
Next Page